Market Access Summit 2026

The 2026 Market Access Summit brings together leading experts, policymakers, industry innovators and patient organisations to examine how market access, health economics and outcomes research (HEOR) can accelerate affordable, equitable access to healthcare innovation across Australia and the region.

The Summit arrives at a critical moment for Australian market access. The Health Technology Assessment (HTA) Policy and Methods Review is complete, and its 50 recommendations provide a significant blueprint for reforming how Australia assesses and funds health technologies. Yet the path from review to implementation remains a key question for the sector. The absence of dedicated funding for HTA implementation in the 2026–27 Federal Budget has prompted concern from industry and advocacy groups, who are calling for clearer timelines, resourcing and accountability to ensure reform leads to faster, fairer and more transparent patient access. This Summit will unpack what needs to happen next, including modernised assessment pathways, stronger use of data and real-world evidence, greater transparency, deeper consumer engagement and the workforce capability required to deliver meaningful reform.

Key Topics:

• The HTA Review in practice
• Real-world evidence and data
• AI and the evidence base
• Redefining value
• The patient and consumer voice
• Access for new modalities